WhaleWatch logoWhaleWatch
Sign inStart for ₹1
Smart Money Alert
Zim Laboratories Limited logo

Zim Laboratories Limited

IncreasedSAST
ZIMLABPharmaceuticalsMarket Cap₹794 Cr
Stake
11.84% → 19.34%
Deal value
₹26.69 Cr
Shares
40.13 L
Trade date
13 Mar 2026
Since alert+122.2%₹66.51 → ₹147.80
Nifty 50+11.4%
Mathew Cyriac
Mathew Cyriac
Investor
The move

Mathew Cyriac increased his stake in Zim Laboratories from 11.84% to 19.34%, acquiring 40,12,702 shares for ₹26.69 Cr at ₹66.51 apiece through an open market purchase. This transaction crossed the 5% disclosure threshold.

About Zim Laboratories Limited
+ FollowVisit stock

A pharmaceutical manufacturer established in 1989, Zim Laboratories specializes in producing formulation drugs and pre-formulation ingredients for both domestic and international markets. The company operates manufacturing facilities across India with capabilities in drug development, quality assurance, and distribution. It serves healthcare providers and patients through a diversified portfolio of therapeutic formulations marketed within India and exported to markets worldwide.

About Mathew Cyriac
+ FollowVisit investor

Led Blackstone India's private equity business and transformed companies like Gokaldas Exports and MTAR Technologies into industry champions. IIM Bangalore gold medallist. Founded Florintree Advisors to continue backing pre-IPO growth platforms such as Data Patterns and IdeaForge. His listed equity bets reflect the same PE discipline: a 19%+ stake in ZIM Laboratories, ~3% in Reliance Infra. Concentrated, long-duration, with an operator's eye for what actually creates value.

Get the next move the moment it happens.
Follow Mathew Cyriac and Zim Laboratories Limited on WhaleWatch, alongside 300+ top investors, funds and FPIs. The newest moves are waiting for you inside.
Explore
Zim Laboratories Limited shareholdersMathew Cyriac's portfolioAll investorsAll stocks
🤖 We track their every move, post, interview and article. Obsessively.
⚡ Every move reaches your feed in minutes, while it still carries an edge
📊 Stake changes, bulk deals and insider trades, all tracked in one place
📰 A two-minute morning brief, so you start the day already ahead
Zim Laboratories Limited
More moves in Zim Laboratories Limited
Tata Mutual FundIncreased
Tata Mutual Fund increased its stake in Zim Laboratories from 1.07% to 1.18%, purchasing 59,564 shares.
12 Oct 2026
Read more
Tata Mutual FundNew position
Tata Mutual Fund acquired a new position of 571,629 shares, a 1.07% stake, in Zim Laboratories.
19 Jul 2026
Read more
See all moves
Mathew Cyriac
More moves by Mathew Cyriac
2newest moves
Members only
Xxxxxx Xxxxxxxxxxxx xxxxxxx xxx xxxxx
Xxxxxxxx Xxxxxxxxxxxx xxxxx xx xxxxxxx
Unlock all 2 moves
Reliance Infrastructure LimitedNew position
Mathew Cyriac entered Reliance Infrastructure with 78,10,929 shares, a 1.91% stake.
RELINFRA18 Jul 2026
Read more
Nitco LimitedNew position
Mathew Cyriac bought 20 lakh shares of Nitco Limited for ₹19.01 crore at ₹95.05 apiece in a bulk deal on May 6, 2026. This acquisition represents a 0.83% stake in the company.
NITCO6 May 2026
Read more
See all moves